Targeting the Gut Mucosal Immune System Using Nanomaterials
The gastrointestinal (GI) tract is one the biggest mucosal surface in the body and one of the primary targets for the delivery of therapeutics, including immunotherapies. GI diseases, including, e.g., inflammatory bowel disease and intestinal infections such as cholera, pose a significant public hea...
Saved in:
Main Authors: | Jacob McCright (Author), Ann Ramirez (Author), Mayowa Amosu (Author), Arnav Sinha (Author), Amanda Bogseth (Author), Katharina Maisel (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting Lymphatics for Nanoparticle Drug Delivery
by: Jacob McCright, et al.
Published: (2022) -
Mediators of Gut Mucosal Immunity and Inflammation
by: Ishak Ozel Tekin, et al.
Published: (2015) -
Microbiota, metabolites and mucosal immunity as potential targets of traditional Chinese medicine for respiratory diseases based on the lung-gut crosstalk
by: Wei Wang, et al.
Published: (2024) -
Interaction of Nanomaterials with the Immune System: Role in Nanosafety and Nanomedicinenanomedicine
by: Paulo Bonan
Published: (2018) -
Immune-Modulating Lipid Nanomaterials for the Delivery of Biopharmaceuticals
by: Songhee Kim, et al.
Published: (2023)